Global Prostate Cancer Nuclear Medicine Diagnostics Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Prostate Cancer Nuclear Medicine Diagnostics market size was valued at US$ 704.3 million in 2023. With growing demand in downstream market, the Prostate Cancer Nuclear Medicine Diagnostics is forecast to a readjusted size of US$ 1462 million by 2030 with a CAGR of 11.0% during review period.
The research report highlights the growth potential of the global Prostate Cancer Nuclear Medicine Diagnostics market. Prostate Cancer Nuclear Medicine Diagnostics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Prostate Cancer Nuclear Medicine Diagnostics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Prostate Cancer Nuclear Medicine Diagnostics market.
Nuclear medicine, a type of imaging that uses radioactive materials, is a useful tool to detect and also treat prostate cancer. It is a form of diagnostic imaging that helps radiologists determine the stage of cancer.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The report on Prostate Cancer Nuclear Medicine Diagnostics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Prostate Cancer Nuclear Medicine Diagnostics market. It may include historical data, market segmentation by Type (e.g., SPECT, PET), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Prostate Cancer Nuclear Medicine Diagnostics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Prostate Cancer Nuclear Medicine Diagnostics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Prostate Cancer Nuclear Medicine Diagnostics industry. This include advancements in Prostate Cancer Nuclear Medicine Diagnostics technology, Prostate Cancer Nuclear Medicine Diagnostics new entrants, Prostate Cancer Nuclear Medicine Diagnostics new investment, and other innovations that are shaping the future of Prostate Cancer Nuclear Medicine Diagnostics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Prostate Cancer Nuclear Medicine Diagnostics market. It includes factors influencing customer ' purchasing decisions, preferences for Prostate Cancer Nuclear Medicine Diagnostics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Prostate Cancer Nuclear Medicine Diagnostics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Prostate Cancer Nuclear Medicine Diagnostics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Prostate Cancer Nuclear Medicine Diagnostics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Prostate Cancer Nuclear Medicine Diagnostics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Prostate Cancer Nuclear Medicine Diagnostics market.
Market Segmentation:
Prostate Cancer Nuclear Medicine Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Prostate Cancer Nuclear Medicine Diagnostics market size was valued at US$ 704.3 million in 2023. With growing demand in downstream market, the Prostate Cancer Nuclear Medicine Diagnostics is forecast to a readjusted size of US$ 1462 million by 2030 with a CAGR of 11.0% during review period.
The research report highlights the growth potential of the global Prostate Cancer Nuclear Medicine Diagnostics market. Prostate Cancer Nuclear Medicine Diagnostics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Prostate Cancer Nuclear Medicine Diagnostics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Prostate Cancer Nuclear Medicine Diagnostics market.
Nuclear medicine, a type of imaging that uses radioactive materials, is a useful tool to detect and also treat prostate cancer. It is a form of diagnostic imaging that helps radiologists determine the stage of cancer.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The report on Prostate Cancer Nuclear Medicine Diagnostics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Prostate Cancer Nuclear Medicine Diagnostics market. It may include historical data, market segmentation by Type (e.g., SPECT, PET), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Prostate Cancer Nuclear Medicine Diagnostics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Prostate Cancer Nuclear Medicine Diagnostics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Prostate Cancer Nuclear Medicine Diagnostics industry. This include advancements in Prostate Cancer Nuclear Medicine Diagnostics technology, Prostate Cancer Nuclear Medicine Diagnostics new entrants, Prostate Cancer Nuclear Medicine Diagnostics new investment, and other innovations that are shaping the future of Prostate Cancer Nuclear Medicine Diagnostics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Prostate Cancer Nuclear Medicine Diagnostics market. It includes factors influencing customer ' purchasing decisions, preferences for Prostate Cancer Nuclear Medicine Diagnostics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Prostate Cancer Nuclear Medicine Diagnostics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Prostate Cancer Nuclear Medicine Diagnostics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Prostate Cancer Nuclear Medicine Diagnostics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Prostate Cancer Nuclear Medicine Diagnostics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Prostate Cancer Nuclear Medicine Diagnostics market.
Market Segmentation:
Prostate Cancer Nuclear Medicine Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- SPECT
- PET
- Hospitals
- Clinics
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Blue Earth Diagnostics
- PETNET Solutions
- Cardinal Health
- Lantheus Medical Imaging
- Jubilant Pharma
- NCM-USA
- Progenics Pharma
- Telix Pharma
- ImaginAb
- Theragnostics
- Novartis
- Alliance Medical
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size 2019-2030
2.1.2 Prostate Cancer Nuclear Medicine Diagnostics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Prostate Cancer Nuclear Medicine Diagnostics Segment by Type
2.2.1 SPECT
2.2.2 PET
2.3 Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type
2.3.1 Prostate Cancer Nuclear Medicine Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Type (2019-2024)
2.4 Prostate Cancer Nuclear Medicine Diagnostics Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application
2.5.1 Prostate Cancer Nuclear Medicine Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Application (2019-2024)
3 PROSTATE CANCER NUCLEAR MEDICINE DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Players
3.1.1 Global Prostate Cancer Nuclear Medicine Diagnostics Revenue by Players (2019-2024)
3.1.2 Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Prostate Cancer Nuclear Medicine Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PROSTATE CANCER NUCLEAR MEDICINE DIAGNOSTICS BY REGIONS
4.1 Prostate Cancer Nuclear Medicine Diagnostics Market Size by Regions (2019-2024)
4.2 Americas Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth (2019-2024)
4.3 APAC Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth (2019-2024)
4.4 Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth (2019-2024)
4.5 Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2019-2024)
5.2 Americas Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2019-2024)
5.3 Americas Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region (2019-2024)
6.2 APAC Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2019-2024)
6.3 APAC Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Prostate Cancer Nuclear Medicine Diagnostics by Country (2019-2024)
7.2 Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2019-2024)
7.3 Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics by Region (2019-2024)
8.2 Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2019-2024)
8.3 Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PROSTATE CANCER NUCLEAR MEDICINE DIAGNOSTICS MARKET FORECAST
10.1 Global Prostate Cancer Nuclear Medicine Diagnostics Forecast by Regions (2025-2030)
10.1.1 Global Prostate Cancer Nuclear Medicine Diagnostics Forecast by Regions (2025-2030)
10.1.2 Americas Prostate Cancer Nuclear Medicine Diagnostics Forecast
10.1.3 APAC Prostate Cancer Nuclear Medicine Diagnostics Forecast
10.1.4 Europe Prostate Cancer Nuclear Medicine Diagnostics Forecast
10.1.5 Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Forecast
10.2 Americas Prostate Cancer Nuclear Medicine Diagnostics Forecast by Country (2025-2030)
10.2.1 United States Prostate Cancer Nuclear Medicine Diagnostics Market Forecast
10.2.2 Canada Prostate Cancer Nuclear Medicine Diagnostics Market Forecast
10.2.3 Mexico Prostate Cancer Nuclear Medicine Diagnostics Market Forecast
10.2.4 Brazil Prostate Cancer Nuclear Medicine Diagnostics Market Forecast
10.3 APAC Prostate Cancer Nuclear Medicine Diagnostics Forecast by Region (2025-2030)
10.3.1 China Prostate Cancer Nuclear Medicine Diagnostics Market Forecast
10.3.2 Japan Prostate Cancer Nuclear Medicine Diagnostics Market Forecast
10.3.3 Korea Prostate Cancer Nuclear Medicine Diagnostics Market Forecast
10.3.4 Southeast Asia Prostate Cancer Nuclear Medicine Diagnostics Market Forecast
10.3.5 India Prostate Cancer Nuclear Medicine Diagnostics Market Forecast
10.3.6 Australia Prostate Cancer Nuclear Medicine Diagnostics Market Forecast
10.4 Europe Prostate Cancer Nuclear Medicine Diagnostics Forecast by Country (2025-2030)
10.4.1 Germany Prostate Cancer Nuclear Medicine Diagnostics Market Forecast
10.4.2 France Prostate Cancer Nuclear Medicine Diagnostics Market Forecast
10.4.3 UK Prostate Cancer Nuclear Medicine Diagnostics Market Forecast
10.4.4 Italy Prostate Cancer Nuclear Medicine Diagnostics Market Forecast
10.4.5 Russia Prostate Cancer Nuclear Medicine Diagnostics Market Forecast
10.5 Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Forecast by Region (2025-2030)
10.5.1 Egypt Prostate Cancer Nuclear Medicine Diagnostics Market Forecast
10.5.2 South Africa Prostate Cancer Nuclear Medicine Diagnostics Market Forecast
10.5.3 Israel Prostate Cancer Nuclear Medicine Diagnostics Market Forecast
10.5.4 Turkey Prostate Cancer Nuclear Medicine Diagnostics Market Forecast
10.5.5 GCC Countries Prostate Cancer Nuclear Medicine Diagnostics Market Forecast
10.6 Global Prostate Cancer Nuclear Medicine Diagnostics Forecast by Type (2025-2030)
10.7 Global Prostate Cancer Nuclear Medicine Diagnostics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Blue Earth Diagnostics
11.1.1 Blue Earth Diagnostics Company Information
11.1.2 Blue Earth Diagnostics Prostate Cancer Nuclear Medicine Diagnostics Product Offered
11.1.3 Blue Earth Diagnostics Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Blue Earth Diagnostics Main Business Overview
11.1.5 Blue Earth Diagnostics Latest Developments
11.2 PETNET Solutions
11.2.1 PETNET Solutions Company Information
11.2.2 PETNET Solutions Prostate Cancer Nuclear Medicine Diagnostics Product Offered
11.2.3 PETNET Solutions Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 PETNET Solutions Main Business Overview
11.2.5 PETNET Solutions Latest Developments
11.3 Cardinal Health
11.3.1 Cardinal Health Company Information
11.3.2 Cardinal Health Prostate Cancer Nuclear Medicine Diagnostics Product Offered
11.3.3 Cardinal Health Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Cardinal Health Main Business Overview
11.3.5 Cardinal Health Latest Developments
11.4 Lantheus Medical Imaging
11.4.1 Lantheus Medical Imaging Company Information
11.4.2 Lantheus Medical Imaging Prostate Cancer Nuclear Medicine Diagnostics Product Offered
11.4.3 Lantheus Medical Imaging Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Lantheus Medical Imaging Main Business Overview
11.4.5 Lantheus Medical Imaging Latest Developments
11.5 Jubilant Pharma
11.5.1 Jubilant Pharma Company Information
11.5.2 Jubilant Pharma Prostate Cancer Nuclear Medicine Diagnostics Product Offered
11.5.3 Jubilant Pharma Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Jubilant Pharma Main Business Overview
11.5.5 Jubilant Pharma Latest Developments
11.6 NCM-USA
11.6.1 NCM-USA Company Information
11.6.2 NCM-USA Prostate Cancer Nuclear Medicine Diagnostics Product Offered
11.6.3 NCM-USA Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 NCM-USA Main Business Overview
11.6.5 NCM-USA Latest Developments
11.7 Progenics Pharma
11.7.1 Progenics Pharma Company Information
11.7.2 Progenics Pharma Prostate Cancer Nuclear Medicine Diagnostics Product Offered
11.7.3 Progenics Pharma Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Progenics Pharma Main Business Overview
11.7.5 Progenics Pharma Latest Developments
11.8 Telix Pharma
11.8.1 Telix Pharma Company Information
11.8.2 Telix Pharma Prostate Cancer Nuclear Medicine Diagnostics Product Offered
11.8.3 Telix Pharma Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Telix Pharma Main Business Overview
11.8.5 Telix Pharma Latest Developments
11.9 ImaginAb
11.9.1 ImaginAb Company Information
11.9.2 ImaginAb Prostate Cancer Nuclear Medicine Diagnostics Product Offered
11.9.3 ImaginAb Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 ImaginAb Main Business Overview
11.9.5 ImaginAb Latest Developments
11.10 Theragnostics
11.10.1 Theragnostics Company Information
11.10.2 Theragnostics Prostate Cancer Nuclear Medicine Diagnostics Product Offered
11.10.3 Theragnostics Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Theragnostics Main Business Overview
11.10.5 Theragnostics Latest Developments
11.11 Novartis
11.11.1 Novartis Company Information
11.11.2 Novartis Prostate Cancer Nuclear Medicine Diagnostics Product Offered
11.11.3 Novartis Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Novartis Main Business Overview
11.11.5 Novartis Latest Developments
11.12 Alliance Medical
11.12.1 Alliance Medical Company Information
11.12.2 Alliance Medical Prostate Cancer Nuclear Medicine Diagnostics Product Offered
11.12.3 Alliance Medical Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Alliance Medical Main Business Overview
11.12.5 Alliance Medical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size 2019-2030
2.1.2 Prostate Cancer Nuclear Medicine Diagnostics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Prostate Cancer Nuclear Medicine Diagnostics Segment by Type
2.2.1 SPECT
2.2.2 PET
2.3 Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type
2.3.1 Prostate Cancer Nuclear Medicine Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Type (2019-2024)
2.4 Prostate Cancer Nuclear Medicine Diagnostics Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application
2.5.1 Prostate Cancer Nuclear Medicine Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Application (2019-2024)
3 PROSTATE CANCER NUCLEAR MEDICINE DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Players
3.1.1 Global Prostate Cancer Nuclear Medicine Diagnostics Revenue by Players (2019-2024)
3.1.2 Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Prostate Cancer Nuclear Medicine Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PROSTATE CANCER NUCLEAR MEDICINE DIAGNOSTICS BY REGIONS
4.1 Prostate Cancer Nuclear Medicine Diagnostics Market Size by Regions (2019-2024)
4.2 Americas Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth (2019-2024)
4.3 APAC Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth (2019-2024)
4.4 Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth (2019-2024)
4.5 Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2019-2024)
5.2 Americas Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2019-2024)
5.3 Americas Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region (2019-2024)
6.2 APAC Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2019-2024)
6.3 APAC Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Prostate Cancer Nuclear Medicine Diagnostics by Country (2019-2024)
7.2 Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2019-2024)
7.3 Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics by Region (2019-2024)
8.2 Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2019-2024)
8.3 Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PROSTATE CANCER NUCLEAR MEDICINE DIAGNOSTICS MARKET FORECAST
10.1 Global Prostate Cancer Nuclear Medicine Diagnostics Forecast by Regions (2025-2030)
10.1.1 Global Prostate Cancer Nuclear Medicine Diagnostics Forecast by Regions (2025-2030)
10.1.2 Americas Prostate Cancer Nuclear Medicine Diagnostics Forecast
10.1.3 APAC Prostate Cancer Nuclear Medicine Diagnostics Forecast
10.1.4 Europe Prostate Cancer Nuclear Medicine Diagnostics Forecast
10.1.5 Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Forecast
10.2 Americas Prostate Cancer Nuclear Medicine Diagnostics Forecast by Country (2025-2030)
10.2.1 United States Prostate Cancer Nuclear Medicine Diagnostics Market Forecast
10.2.2 Canada Prostate Cancer Nuclear Medicine Diagnostics Market Forecast
10.2.3 Mexico Prostate Cancer Nuclear Medicine Diagnostics Market Forecast
10.2.4 Brazil Prostate Cancer Nuclear Medicine Diagnostics Market Forecast
10.3 APAC Prostate Cancer Nuclear Medicine Diagnostics Forecast by Region (2025-2030)
10.3.1 China Prostate Cancer Nuclear Medicine Diagnostics Market Forecast
10.3.2 Japan Prostate Cancer Nuclear Medicine Diagnostics Market Forecast
10.3.3 Korea Prostate Cancer Nuclear Medicine Diagnostics Market Forecast
10.3.4 Southeast Asia Prostate Cancer Nuclear Medicine Diagnostics Market Forecast
10.3.5 India Prostate Cancer Nuclear Medicine Diagnostics Market Forecast
10.3.6 Australia Prostate Cancer Nuclear Medicine Diagnostics Market Forecast
10.4 Europe Prostate Cancer Nuclear Medicine Diagnostics Forecast by Country (2025-2030)
10.4.1 Germany Prostate Cancer Nuclear Medicine Diagnostics Market Forecast
10.4.2 France Prostate Cancer Nuclear Medicine Diagnostics Market Forecast
10.4.3 UK Prostate Cancer Nuclear Medicine Diagnostics Market Forecast
10.4.4 Italy Prostate Cancer Nuclear Medicine Diagnostics Market Forecast
10.4.5 Russia Prostate Cancer Nuclear Medicine Diagnostics Market Forecast
10.5 Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Forecast by Region (2025-2030)
10.5.1 Egypt Prostate Cancer Nuclear Medicine Diagnostics Market Forecast
10.5.2 South Africa Prostate Cancer Nuclear Medicine Diagnostics Market Forecast
10.5.3 Israel Prostate Cancer Nuclear Medicine Diagnostics Market Forecast
10.5.4 Turkey Prostate Cancer Nuclear Medicine Diagnostics Market Forecast
10.5.5 GCC Countries Prostate Cancer Nuclear Medicine Diagnostics Market Forecast
10.6 Global Prostate Cancer Nuclear Medicine Diagnostics Forecast by Type (2025-2030)
10.7 Global Prostate Cancer Nuclear Medicine Diagnostics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Blue Earth Diagnostics
11.1.1 Blue Earth Diagnostics Company Information
11.1.2 Blue Earth Diagnostics Prostate Cancer Nuclear Medicine Diagnostics Product Offered
11.1.3 Blue Earth Diagnostics Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Blue Earth Diagnostics Main Business Overview
11.1.5 Blue Earth Diagnostics Latest Developments
11.2 PETNET Solutions
11.2.1 PETNET Solutions Company Information
11.2.2 PETNET Solutions Prostate Cancer Nuclear Medicine Diagnostics Product Offered
11.2.3 PETNET Solutions Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 PETNET Solutions Main Business Overview
11.2.5 PETNET Solutions Latest Developments
11.3 Cardinal Health
11.3.1 Cardinal Health Company Information
11.3.2 Cardinal Health Prostate Cancer Nuclear Medicine Diagnostics Product Offered
11.3.3 Cardinal Health Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Cardinal Health Main Business Overview
11.3.5 Cardinal Health Latest Developments
11.4 Lantheus Medical Imaging
11.4.1 Lantheus Medical Imaging Company Information
11.4.2 Lantheus Medical Imaging Prostate Cancer Nuclear Medicine Diagnostics Product Offered
11.4.3 Lantheus Medical Imaging Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Lantheus Medical Imaging Main Business Overview
11.4.5 Lantheus Medical Imaging Latest Developments
11.5 Jubilant Pharma
11.5.1 Jubilant Pharma Company Information
11.5.2 Jubilant Pharma Prostate Cancer Nuclear Medicine Diagnostics Product Offered
11.5.3 Jubilant Pharma Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Jubilant Pharma Main Business Overview
11.5.5 Jubilant Pharma Latest Developments
11.6 NCM-USA
11.6.1 NCM-USA Company Information
11.6.2 NCM-USA Prostate Cancer Nuclear Medicine Diagnostics Product Offered
11.6.3 NCM-USA Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 NCM-USA Main Business Overview
11.6.5 NCM-USA Latest Developments
11.7 Progenics Pharma
11.7.1 Progenics Pharma Company Information
11.7.2 Progenics Pharma Prostate Cancer Nuclear Medicine Diagnostics Product Offered
11.7.3 Progenics Pharma Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Progenics Pharma Main Business Overview
11.7.5 Progenics Pharma Latest Developments
11.8 Telix Pharma
11.8.1 Telix Pharma Company Information
11.8.2 Telix Pharma Prostate Cancer Nuclear Medicine Diagnostics Product Offered
11.8.3 Telix Pharma Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Telix Pharma Main Business Overview
11.8.5 Telix Pharma Latest Developments
11.9 ImaginAb
11.9.1 ImaginAb Company Information
11.9.2 ImaginAb Prostate Cancer Nuclear Medicine Diagnostics Product Offered
11.9.3 ImaginAb Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 ImaginAb Main Business Overview
11.9.5 ImaginAb Latest Developments
11.10 Theragnostics
11.10.1 Theragnostics Company Information
11.10.2 Theragnostics Prostate Cancer Nuclear Medicine Diagnostics Product Offered
11.10.3 Theragnostics Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Theragnostics Main Business Overview
11.10.5 Theragnostics Latest Developments
11.11 Novartis
11.11.1 Novartis Company Information
11.11.2 Novartis Prostate Cancer Nuclear Medicine Diagnostics Product Offered
11.11.3 Novartis Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Novartis Main Business Overview
11.11.5 Novartis Latest Developments
11.12 Alliance Medical
11.12.1 Alliance Medical Company Information
11.12.2 Alliance Medical Prostate Cancer Nuclear Medicine Diagnostics Product Offered
11.12.3 Alliance Medical Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Alliance Medical Main Business Overview
11.12.5 Alliance Medical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Prostate Cancer Nuclear Medicine Diagnostics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of SPECT
Table 3. Major Players of PET
Table 4. Prostate Cancer Nuclear Medicine Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Type (2019-2024)
Table 7. Prostate Cancer Nuclear Medicine Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Application (2019-2024)
Table 10. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Player (2019-2024)
Table 12. Prostate Cancer Nuclear Medicine Diagnostics Key Players Head office and Products Offered
Table 13. Prostate Cancer Nuclear Medicine Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Regions (2019-2024)
Table 18. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Country (2019-2024)
Table 22. Americas Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Type (2019-2024)
Table 24. Americas Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Application (2019-2024)
Table 26. APAC Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Region (2019-2024)
Table 28. APAC Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Type (2019-2024)
Table 30. APAC Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Application (2019-2024)
Table 32. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Country (2019-2024)
Table 34. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Type (2019-2024)
Table 36. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Prostate Cancer Nuclear Medicine Diagnostics
Table 45. Key Market Challenges & Risks of Prostate Cancer Nuclear Medicine Diagnostics
Table 46. Key Industry Trends of Prostate Cancer Nuclear Medicine Diagnostics
Table 47. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Blue Earth Diagnostics Details, Company Type, Prostate Cancer Nuclear Medicine Diagnostics Area Served and Its Competitors
Table 52. Blue Earth Diagnostics Prostate Cancer Nuclear Medicine Diagnostics Product Offered
Table 53. Blue Earth Diagnostics Prostate Cancer Nuclear Medicine Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Blue Earth Diagnostics Main Business
Table 55. Blue Earth Diagnostics Latest Developments
Table 56. PETNET Solutions Details, Company Type, Prostate Cancer Nuclear Medicine Diagnostics Area Served and Its Competitors
Table 57. PETNET Solutions Prostate Cancer Nuclear Medicine Diagnostics Product Offered
Table 58. PETNET Solutions Main Business
Table 59. PETNET Solutions Prostate Cancer Nuclear Medicine Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. PETNET Solutions Latest Developments
Table 61. Cardinal Health Details, Company Type, Prostate Cancer Nuclear Medicine Diagnostics Area Served and Its Competitors
Table 62. Cardinal Health Prostate Cancer Nuclear Medicine Diagnostics Product Offered
Table 63. Cardinal Health Main Business
Table 64. Cardinal Health Prostate Cancer Nuclear Medicine Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Cardinal Health Latest Developments
Table 66. Lantheus Medical Imaging Details, Company Type, Prostate Cancer Nuclear Medicine Diagnostics Area Served and Its Competitors
Table 67. Lantheus Medical Imaging Prostate Cancer Nuclear Medicine Diagnostics Product Offered
Table 68. Lantheus Medical Imaging Main Business
Table 69. Lantheus Medical Imaging Prostate Cancer Nuclear Medicine Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Lantheus Medical Imaging Latest Developments
Table 71. Jubilant Pharma Details, Company Type, Prostate Cancer Nuclear Medicine Diagnostics Area Served and Its Competitors
Table 72. Jubilant Pharma Prostate Cancer Nuclear Medicine Diagnostics Product Offered
Table 73. Jubilant Pharma Main Business
Table 74. Jubilant Pharma Prostate Cancer Nuclear Medicine Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Jubilant Pharma Latest Developments
Table 76. NCM-USA Details, Company Type, Prostate Cancer Nuclear Medicine Diagnostics Area Served and Its Competitors
Table 77. NCM-USA Prostate Cancer Nuclear Medicine Diagnostics Product Offered
Table 78. NCM-USA Main Business
Table 79. NCM-USA Prostate Cancer Nuclear Medicine Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. NCM-USA Latest Developments
Table 81. Progenics Pharma Details, Company Type, Prostate Cancer Nuclear Medicine Diagnostics Area Served and Its Competitors
Table 82. Progenics Pharma Prostate Cancer Nuclear Medicine Diagnostics Product Offered
Table 83. Progenics Pharma Main Business
Table 84. Progenics Pharma Prostate Cancer Nuclear Medicine Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Progenics Pharma Latest Developments
Table 86. Telix Pharma Details, Company Type, Prostate Cancer Nuclear Medicine Diagnostics Area Served and Its Competitors
Table 87. Telix Pharma Prostate Cancer Nuclear Medicine Diagnostics Product Offered
Table 88. Telix Pharma Main Business
Table 89. Telix Pharma Prostate Cancer Nuclear Medicine Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Telix Pharma Latest Developments
Table 91. ImaginAb Details, Company Type, Prostate Cancer Nuclear Medicine Diagnostics Area Served and Its Competitors
Table 92. ImaginAb Prostate Cancer Nuclear Medicine Diagnostics Product Offered
Table 93. ImaginAb Main Business
Table 94. ImaginAb Prostate Cancer Nuclear Medicine Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. ImaginAb Latest Developments
Table 96. Theragnostics Details, Company Type, Prostate Cancer Nuclear Medicine Diagnostics Area Served and Its Competitors
Table 97. Theragnostics Prostate Cancer Nuclear Medicine Diagnostics Product Offered
Table 98. Theragnostics Main Business
Table 99. Theragnostics Prostate Cancer Nuclear Medicine Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Theragnostics Latest Developments
Table 101. Novartis Details, Company Type, Prostate Cancer Nuclear Medicine Diagnostics Area Served and Its Competitors
Table 102. Novartis Prostate Cancer Nuclear Medicine Diagnostics Product Offered
Table 103. Novartis Prostate Cancer Nuclear Medicine Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Novartis Main Business
Table 105. Novartis Latest Developments
Table 106. Alliance Medical Details, Company Type, Prostate Cancer Nuclear Medicine Diagnostics Area Served and Its Competitors
Table 107. Alliance Medical Prostate Cancer Nuclear Medicine Diagnostics Product Offered
Table 108. Alliance Medical Main Business
Table 109. Alliance Medical Prostate Cancer Nuclear Medicine Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Alliance Medical Latest Developments
Table 1. Prostate Cancer Nuclear Medicine Diagnostics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of SPECT
Table 3. Major Players of PET
Table 4. Prostate Cancer Nuclear Medicine Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Type (2019-2024)
Table 7. Prostate Cancer Nuclear Medicine Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Application (2019-2024)
Table 10. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Player (2019-2024)
Table 12. Prostate Cancer Nuclear Medicine Diagnostics Key Players Head office and Products Offered
Table 13. Prostate Cancer Nuclear Medicine Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Regions (2019-2024)
Table 18. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Country (2019-2024)
Table 22. Americas Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Type (2019-2024)
Table 24. Americas Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Application (2019-2024)
Table 26. APAC Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Region (2019-2024)
Table 28. APAC Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Type (2019-2024)
Table 30. APAC Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Application (2019-2024)
Table 32. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Country (2019-2024)
Table 34. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Type (2019-2024)
Table 36. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Prostate Cancer Nuclear Medicine Diagnostics
Table 45. Key Market Challenges & Risks of Prostate Cancer Nuclear Medicine Diagnostics
Table 46. Key Industry Trends of Prostate Cancer Nuclear Medicine Diagnostics
Table 47. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Blue Earth Diagnostics Details, Company Type, Prostate Cancer Nuclear Medicine Diagnostics Area Served and Its Competitors
Table 52. Blue Earth Diagnostics Prostate Cancer Nuclear Medicine Diagnostics Product Offered
Table 53. Blue Earth Diagnostics Prostate Cancer Nuclear Medicine Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Blue Earth Diagnostics Main Business
Table 55. Blue Earth Diagnostics Latest Developments
Table 56. PETNET Solutions Details, Company Type, Prostate Cancer Nuclear Medicine Diagnostics Area Served and Its Competitors
Table 57. PETNET Solutions Prostate Cancer Nuclear Medicine Diagnostics Product Offered
Table 58. PETNET Solutions Main Business
Table 59. PETNET Solutions Prostate Cancer Nuclear Medicine Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. PETNET Solutions Latest Developments
Table 61. Cardinal Health Details, Company Type, Prostate Cancer Nuclear Medicine Diagnostics Area Served and Its Competitors
Table 62. Cardinal Health Prostate Cancer Nuclear Medicine Diagnostics Product Offered
Table 63. Cardinal Health Main Business
Table 64. Cardinal Health Prostate Cancer Nuclear Medicine Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Cardinal Health Latest Developments
Table 66. Lantheus Medical Imaging Details, Company Type, Prostate Cancer Nuclear Medicine Diagnostics Area Served and Its Competitors
Table 67. Lantheus Medical Imaging Prostate Cancer Nuclear Medicine Diagnostics Product Offered
Table 68. Lantheus Medical Imaging Main Business
Table 69. Lantheus Medical Imaging Prostate Cancer Nuclear Medicine Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Lantheus Medical Imaging Latest Developments
Table 71. Jubilant Pharma Details, Company Type, Prostate Cancer Nuclear Medicine Diagnostics Area Served and Its Competitors
Table 72. Jubilant Pharma Prostate Cancer Nuclear Medicine Diagnostics Product Offered
Table 73. Jubilant Pharma Main Business
Table 74. Jubilant Pharma Prostate Cancer Nuclear Medicine Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Jubilant Pharma Latest Developments
Table 76. NCM-USA Details, Company Type, Prostate Cancer Nuclear Medicine Diagnostics Area Served and Its Competitors
Table 77. NCM-USA Prostate Cancer Nuclear Medicine Diagnostics Product Offered
Table 78. NCM-USA Main Business
Table 79. NCM-USA Prostate Cancer Nuclear Medicine Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. NCM-USA Latest Developments
Table 81. Progenics Pharma Details, Company Type, Prostate Cancer Nuclear Medicine Diagnostics Area Served and Its Competitors
Table 82. Progenics Pharma Prostate Cancer Nuclear Medicine Diagnostics Product Offered
Table 83. Progenics Pharma Main Business
Table 84. Progenics Pharma Prostate Cancer Nuclear Medicine Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Progenics Pharma Latest Developments
Table 86. Telix Pharma Details, Company Type, Prostate Cancer Nuclear Medicine Diagnostics Area Served and Its Competitors
Table 87. Telix Pharma Prostate Cancer Nuclear Medicine Diagnostics Product Offered
Table 88. Telix Pharma Main Business
Table 89. Telix Pharma Prostate Cancer Nuclear Medicine Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Telix Pharma Latest Developments
Table 91. ImaginAb Details, Company Type, Prostate Cancer Nuclear Medicine Diagnostics Area Served and Its Competitors
Table 92. ImaginAb Prostate Cancer Nuclear Medicine Diagnostics Product Offered
Table 93. ImaginAb Main Business
Table 94. ImaginAb Prostate Cancer Nuclear Medicine Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. ImaginAb Latest Developments
Table 96. Theragnostics Details, Company Type, Prostate Cancer Nuclear Medicine Diagnostics Area Served and Its Competitors
Table 97. Theragnostics Prostate Cancer Nuclear Medicine Diagnostics Product Offered
Table 98. Theragnostics Main Business
Table 99. Theragnostics Prostate Cancer Nuclear Medicine Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Theragnostics Latest Developments
Table 101. Novartis Details, Company Type, Prostate Cancer Nuclear Medicine Diagnostics Area Served and Its Competitors
Table 102. Novartis Prostate Cancer Nuclear Medicine Diagnostics Product Offered
Table 103. Novartis Prostate Cancer Nuclear Medicine Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Novartis Main Business
Table 105. Novartis Latest Developments
Table 106. Alliance Medical Details, Company Type, Prostate Cancer Nuclear Medicine Diagnostics Area Served and Its Competitors
Table 107. Alliance Medical Prostate Cancer Nuclear Medicine Diagnostics Product Offered
Table 108. Alliance Medical Main Business
Table 109. Alliance Medical Prostate Cancer Nuclear Medicine Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Alliance Medical Latest Developments
LIST OF FIGURES
Figure 1. Prostate Cancer Nuclear Medicine Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Prostate Cancer Nuclear Medicine Diagnostics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Prostate Cancer Nuclear Medicine Diagnostics Sales Market Share by Country/Region (2023)
Figure 8. Prostate Cancer Nuclear Medicine Diagnostics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Type in 2023
Figure 10. Prostate Cancer Nuclear Medicine Diagnostics in Hospitals
Figure 11. Global Prostate Cancer Nuclear Medicine Diagnostics Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Prostate Cancer Nuclear Medicine Diagnostics in Clinics
Figure 13. Global Prostate Cancer Nuclear Medicine Diagnostics Market: Clinics (2019-2024) & ($ Millions)
Figure 14. Prostate Cancer Nuclear Medicine Diagnostics in Others
Figure 15. Global Prostate Cancer Nuclear Medicine Diagnostics Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Application in 2023
Figure 17. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Player in 2023
Figure 18. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Prostate Cancer Nuclear Medicine Diagnostics Market Size 2019-2024 ($ Millions)
Figure 20. APAC Prostate Cancer Nuclear Medicine Diagnostics Market Size 2019-2024 ($ Millions)
Figure 21. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size 2019-2024 ($ Millions)
Figure 23. Americas Prostate Cancer Nuclear Medicine Diagnostics Value Market Share by Country in 2023
Figure 24. United States Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Region in 2023
Figure 29. APAC Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Type in 2023
Figure 30. APAC Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Application in 2023
Figure 31. China Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Country in 2023
Figure 38. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Type (2019-2024)
Figure 39. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Application (2019-2024)
Figure 40. Germany Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 54. APAC Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 55. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 57. United States Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 58. Canada Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 61. China Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 62. Japan Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 63. Korea Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 65. India Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 66. Australia Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 67. Germany Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 68. France Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 69. UK Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 70. Italy Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 71. Russia Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 72. Spain Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 75. Israel Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 78. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Prostate Cancer Nuclear Medicine Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Prostate Cancer Nuclear Medicine Diagnostics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Prostate Cancer Nuclear Medicine Diagnostics Sales Market Share by Country/Region (2023)
Figure 8. Prostate Cancer Nuclear Medicine Diagnostics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Type in 2023
Figure 10. Prostate Cancer Nuclear Medicine Diagnostics in Hospitals
Figure 11. Global Prostate Cancer Nuclear Medicine Diagnostics Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Prostate Cancer Nuclear Medicine Diagnostics in Clinics
Figure 13. Global Prostate Cancer Nuclear Medicine Diagnostics Market: Clinics (2019-2024) & ($ Millions)
Figure 14. Prostate Cancer Nuclear Medicine Diagnostics in Others
Figure 15. Global Prostate Cancer Nuclear Medicine Diagnostics Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Application in 2023
Figure 17. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Player in 2023
Figure 18. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Prostate Cancer Nuclear Medicine Diagnostics Market Size 2019-2024 ($ Millions)
Figure 20. APAC Prostate Cancer Nuclear Medicine Diagnostics Market Size 2019-2024 ($ Millions)
Figure 21. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size 2019-2024 ($ Millions)
Figure 23. Americas Prostate Cancer Nuclear Medicine Diagnostics Value Market Share by Country in 2023
Figure 24. United States Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Region in 2023
Figure 29. APAC Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Type in 2023
Figure 30. APAC Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Application in 2023
Figure 31. China Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Country in 2023
Figure 38. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Type (2019-2024)
Figure 39. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Application (2019-2024)
Figure 40. Germany Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 54. APAC Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 55. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 57. United States Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 58. Canada Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 61. China Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 62. Japan Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 63. Korea Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 65. India Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 66. Australia Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 67. Germany Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 68. France Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 69. UK Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 70. Italy Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 71. Russia Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 72. Spain Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 75. Israel Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Prostate Cancer Nuclear Medicine Diagnostics Market Size 2025-2030 ($ Millions)
Figure 78. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share Forecast by Application (2025-2030)
